CHD5 and CTDSPL possess tumor suppressor activities in many cancers, including neuroblastomas, gliomas, and Non-Small Cell Lung Cancer (NSCLC) [65–67, 86]. The gene discussed is CHD5; the disease is central nervous system cancer.